期刊文献+

CD40-CD40L与OX40在急性髓性白血病中的表达意义 被引量:1

The Expression of CD40/CD40L and OX40 in Acute Myeloid Leukaemia
下载PDF
导出
摘要 目的:检测在急性髓性白血病细胞中CD40、CD40L、OX40的表达并探讨其临床意义。方法:应用流式细胞仪检测46例未经治疗的初诊急性髓性白血病患者骨髓单个核细胞表面CD40、CD40L、OX40的表达,分为四组:仅表达CD40的患者组(①组)、表达CD40+CD40L+OX40-的患者组(②组)、三种抗原全部表达组(③组)和全部不表达组(④组)。利用SPSS统计软件分析。结果:在有高白细胞表现的患者中,②组的发病率(100%)最高;在有血小板减少表现的患者中,①组的发病率(100%)最高;在有脾大表现的患者中,④组的发病率(6.7%)最低。结论:CD40的单独表达可能使白血病患者血小板的降低更加严重,而当合并CD40L表达时,会减少血小板低下的发生率。CD40的表达能增加患者伴有脾大表现的可能性。 Objective:To detect the expression of CD40/CD40L and OX40 in acute myeloid leukaemia (AML) and explore its clinical significance. Methods: using flow eytometry (FCM) to detect the expression of CD40, CD40L, OX40 on mononuclear cells which were from 46 untreated patients with newly diagnosed AML. Then separation to four groups: the only expression CD40 antigen group (1), the expression CD40+ CD40L+OX40- group ((2)), the expression three antigen group (3), the expression none of antigen group (4). Results: In high leukocyte symptom patients, group (2) incidence was highest; in thrombocytopenic patients, group (1)incidence( 100% ) was highest; In splenauxe symptom patients group (4) was lowest. Conclusion:The single expression CD40 can lead to heavier low thrombocytic. Together with expression of CD40L can lead to lower incidence of low platelet. The expression of CD40 may increase splenauxe symptom incidence.
出处 《长治医学院学报》 2009年第6期404-407,共4页 Journal of Changzhi Medical College
关键词 白血病 CD40 CD40L OX40 Leukaemia CD40 CD40L OX40
  • 相关文献

参考文献10

  • 1Costello RT, Mallet F, Chambost H, et al. Acute myeloidleukemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allergenic or antotagous leukemia targets[J]. Leukemia,2000,14(1 ) : 123 - 128.
  • 2Li Li, Anita Sehmitt, Peter Reinhardt, et al. Reconstitution of CD40 and CD80 in dendritic eells generated from blasts of patients with acute myeloid leukemia[ J ]. Cancer Immunity,2003,16(3) : 8.
  • 3黄海雯,傅晋翔.CD40-CD40L在血液病中的作用[J].国外医学(输血及血液学分册),2003,26(1):60-62. 被引量:1
  • 4戚春建.CD40L/CD40及CD40突变体在人多发性骨髓瘤中的表达及其生物学意义[D].中国优秀博硕士学位论文全文数据库(博士),2006,11:28-36.
  • 5Aleasandro Ottanato, Anna De Chiara, Franeesco Perrone, et al. Prognostic value of CD40 in adult soft tissue sarcomas[J] .Clinical Cancer Research,2004,10:2824 - 2831.
  • 6Peng DQ,Zhao SP,Li VF, et al. Elevated soluble CIMOligand is related to the endothelial adhesion molecules in patients with aetlte coronary syndrome[J]. Clinical ChimicaAeta, 2002,319( 1 ) : 19 - 26.
  • 7Demirci G, Amanullah F, Kewalaramani R, et al. Critical role of OX40 in CD28 and CD154- independent rejection [J ]. J Immunol, 2004,172(3) :257 - 261.
  • 8Keating MJ, Chiorazzi N, Messmer B, et al. Biology and treatment of chronic lymphocytic leukemia [ J ]. Hematology, 2003,3 : 153 - 175.
  • 9朱芳兵,王少元,张轶文.CD_(40)抗原和生存素基因在急性髓性白血病细胞中表达及其临床意义[J].中华内科杂志,2004,43(10):769-772. 被引量:7
  • 10Aldinucci D, Poletto D,Nanni P, et al. CD40L induces proliferation, self - renewal, rescue from apoptosis, and production of cytokines by CD40 - expressing AML blasts. Exp Hematol, 2002, 30 (11):1283- 1292.

二级参考文献27

  • 1Zeis M, Siegel S, Wagner A, et al. Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells. J Immunol,2003,170:5391-5397.
  • 2Briones J, Timmerman J, Levy R. In vivo antitumor effect of CD40-L-transduced tumor cells as a vaccine for B-cell lymphoma. Cancer Res, 2002,62 :3195-3199.
  • 3Costello RT, Mallet F, Chambost H, et al. Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets. Leukemia, 2000,14 :123-128.
  • 4Aldinucci D, Poletto D, Nanni P, et al.CD40L induces proliferation, self-renewal, rescue from apoptosis , and production of cytokines by CD40-expressing AML blasts. Exp Hematol, 2002,30 :1283-1292.
  • 5Gattei V, Degan M, Gloghini A, et al. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood, 1997, 89:2048-2059.
  • 6Gattei V, Degan M, Rossi FM, et al. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. Leuk Lymphoma,1999,35:21-35.
  • 7Galibert L, Tometsko ME, Anderson DM, et al. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem, 1998,273:34120
  • 8Granziero L, Ghia P, Circosta P, et al.Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood, 2001 ,97:2777-2783,2784-2790.
  • 9Tamm I, Wang Y, Sausville E, et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res, 1998 ,58:5315-5320.
  • 10Chu ZL, McKinsey TA, Liu L, et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A, 1997 ,94:10057-10062.

共引文献6

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部